{
  "id": 803241,
  "title": "WHO recommends Phase III trial of Ebola vaccine against Bundibugyo virus",
  "url": "https://urgent.news/2026/08/13/who-recommends-phase-iii-trial-of-ebola-vaccine-against-bundibugyo",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-13T20:22:36.000Z",
  "source": {
    "name": "Premium Times",
    "slug": "premium-times",
    "url": "https://www.premiumtimesng.com/health/health-news/902712-who-recommends-phase-iii-trial-of-ebola-vaccine-against-bundibugyo-virus.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "The World Health Organization has recommended a Phase III trial of an Ebola vaccine against the Bundibugyo virus. This comes as researchers work on vaccines and treatments for the ongoing Ebola outbreak in the Democratic Republic of the Congo.\n\nThe current outbreak in the DRC is primarily caused by the Bundibugyo virus, a type of Ebola virus. According to The Indian Express, the outbreak is on track to become the deadliest on record, with the WHO warning it could eclipse the 2014-2016 outbreak that killed at least 11,000 people.\n\nThe Bundibugyo virus was first identified in 2007 in western Uganda, near the border with the DRC, resulting in 116 cases and 39 deaths. The Indian Express also notes that each Ebola virus species is 30-40% divergent from one another.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "The Indian Express",
        "title": "What makes controlling Ebola virus challenging",
        "url": "https://urgent.news/2026/08/13/what-makes-controlling-ebola-virus-challenging",
        "published": "2026-08-13T14:37:23.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}